| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
NEXT EVENT: Tuesday 28th November 2017 - The pharmaceutical analysis postgraduate research awards and careers symposium... 
JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
LAST EVENT:
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
Tuesday 28th November 2017
The pharmaceutical analysis postgraduate research awards and careers symposium
Royal Society of Chemistry, London
JPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best podium and poster presentations will be recognised with cash prizes up to 500 GBP.
There will also be plenary lectures by leading scientists and an industrial careers exhibition:
» Professor Melissa Hanna-Brown
Prof Hanna-Brown is Technology & Innovation EU Lead, Pfizer Worldwide R&D, Sandwich, UK and Department of Chemistry, University of Warwick, UK and President of the Analytical Division, Royal Society Chemistry, UK.
» Professor Trevor Jones CBE
Prof Jones is Chairman of the international Clinical Research Organisation, Simbec-Orion, a member of the Boards of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF) .Formerly he was Director of Allergan Inc (USA) and R&D Director of The Wellcome Foundation.
Speakers:
Prof Melissa Hanna-Brown - Pfizer Global R&D
Prof Trevor Jones - King's College London
Enas Al-Ani - University of Wolverhampton
Daniel Baker - University Of Hertfordshire
Asma Buanz - UCL School of Pharmacy
Gonçalo Farias - University of Bath
Matthew Hulme - Manchester Metropolitan University
Philip Lynch - Queen's University Belfast
Dr Laura Palmer - GlaxoSmithKline
Dr Eleanor Turpin - University of Nottingham
Afaf Al Groshi - Liverpool John Moores University
Ruba Bnyan - Liverpool John Moores University
Shane Cullen - Queen's University Belfast
James Gooch - King's College London
Emmanouela Kampouraki - Newcastle University
Dinesh Kapu - Athlone Institute of Technology
Natalie Orr - Queen's University Belfast
Nazia Rafique - University of Hertfordshire
Jim Roche - Athlone Institute of Technology
DETAILS AND BOOKING
The pharmaceutical analysis postgraduate research awards and careers symposium
Royal Society of Chemistry, London
JPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best podium and poster presentations will be recognised with cash prizes up to 500 GBP.There will also be plenary lectures by leading scientists and an industrial careers exhibition:
» Professor Melissa Hanna-Brown
Prof Hanna-Brown is Technology & Innovation EU Lead, Pfizer Worldwide R&D, Sandwich, UK and Department of Chemistry, University of Warwick, UK and President of the Analytical Division, Royal Society Chemistry, UK.
» Professor Trevor Jones CBE
Prof Jones is Chairman of the international Clinical Research Organisation, Simbec-Orion, a member of the Boards of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF) .Formerly he was Director of Allergan Inc (USA) and R&D Director of The Wellcome Foundation.
Speakers:
Prof Melissa Hanna-Brown - Pfizer Global R&D
Prof Trevor Jones - King's College London
Enas Al-Ani - University of Wolverhampton
Daniel Baker - University Of Hertfordshire
Asma Buanz - UCL School of Pharmacy
Gonçalo Farias - University of Bath
Matthew Hulme - Manchester Metropolitan University
Philip Lynch - Queen's University Belfast
Dr Laura Palmer - GlaxoSmithKline
Dr Eleanor Turpin - University of Nottingham
Afaf Al Groshi - Liverpool John Moores University
Ruba Bnyan - Liverpool John Moores University
Shane Cullen - Queen's University Belfast
James Gooch - King's College London
Emmanouela Kampouraki - Newcastle University
Dinesh Kapu - Athlone Institute of Technology
Natalie Orr - Queen's University Belfast
Nazia Rafique - University of Hertfordshire
Jim Roche - Athlone Institute of Technology
DETAILS AND BOOKING
Thursday 7th December 2017
Ensuring amorphous product quality: what are the challenges?
Royal Society of Chemistry, London
Amorphous drug formulation offers great promise in improving drug solubility - a major challenge in drug development. However, poor physical stability and hard to predict crystallisation remains key barriers for the wider use of amorphous solid solution in the pharmaceutical industry.
This symposium will critically examine the challenges and opportunities lie in the analysis of amorphous formulation systems.
Leading industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of amorphous products.
New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.
You will gain latest knowledges on the analysis and manufacturing of amorphous/solid solution products.
You may form new collaborations with experts across academic and industry.
Speakers:
Prof Gavin Andrews - Queens University Belfast
Prof Duncan Craig - University College of London
Dr Korbinian Löbmann - University of Copenhagen
Dr Claire Pizzey - Diamond Light Source
Hans Platteeuw - Avivia
Dr Paul Poyall - Kings College London
Dr Abhishek Singh - Johnson & Johnson
Dr Krzysztof Sollohub - Catalent
DETAILS AND BOOKING
Ensuring amorphous product quality: what are the challenges?
Royal Society of Chemistry, London
Amorphous drug formulation offers great promise in improving drug solubility - a major challenge in drug development. However, poor physical stability and hard to predict crystallisation remains key barriers for the wider use of amorphous solid solution in the pharmaceutical industry.
This symposium will critically examine the challenges and opportunities lie in the analysis of amorphous formulation systems.
Leading industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of amorphous products.
New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.
You will gain latest knowledges on the analysis and manufacturing of amorphous/solid solution products.
You may form new collaborations with experts across academic and industry.
Speakers:
Prof Gavin Andrews - Queens University Belfast
Prof Duncan Craig - University College of London
Dr Korbinian Löbmann - University of Copenhagen
Dr Claire Pizzey - Diamond Light Source
Hans Platteeuw - Avivia
Dr Paul Poyall - Kings College London
Dr Abhishek Singh - Johnson & Johnson
Dr Krzysztof Sollohub - Catalent
DETAILS AND BOOKING
Thursday 8th February 2018
Cleaning validation
Royal Society of Chemistry, London
Continuing our successful continuing programme of pharmaceutical analysis symposia, this meeting will focus on cleaning validation and is aimed at providing the latest regulatory expectations and best practice information in the domain of cleaning validation since the publication of the European Medicines Agency Shared Facilities Guideline and subsequent Q&A Document.
The meeting will explore cleaning validation requirements from a toxicologists perspective and also examine new facility design considerations to minimise the potential for cross contamination.
There will be ample opportunity to interact with the expert speakers during Q&A sessions and panel discussions throughout the day and informally during lunch and refreshment breaks.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance , Manufacturing and Validation in the Pharmaceutical and Biotech Industry, NHS manufacturing units, Contract Manufacturing Organisations, consulting, academia, and anyone else concerned with the management and assessment of cleaning validation.
DETAILS AND BOOKING
Cleaning validation
Royal Society of Chemistry, London
Continuing our successful continuing programme of pharmaceutical analysis symposia, this meeting will focus on cleaning validation and is aimed at providing the latest regulatory expectations and best practice information in the domain of cleaning validation since the publication of the European Medicines Agency Shared Facilities Guideline and subsequent Q&A Document.
The meeting will explore cleaning validation requirements from a toxicologists perspective and also examine new facility design considerations to minimise the potential for cross contamination.
There will be ample opportunity to interact with the expert speakers during Q&A sessions and panel discussions throughout the day and informally during lunch and refreshment breaks.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance , Manufacturing and Validation in the Pharmaceutical and Biotech Industry, NHS manufacturing units, Contract Manufacturing Organisations, consulting, academia, and anyone else concerned with the management and assessment of cleaning validation.
DETAILS AND BOOKING
Thursday 15th March 2018
Continuous manufacturing
Royal Society of Chemistry, London
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of pharmaceutical products. However, despite strong regulatory support aimed at encouraging the early adoption of new technologies, which in turn would facilitate the application of modern quality management techniques to all aspects of pharmaceutical production and quality assurance; uptake by Industry has been very slow.
This symposium, held in partnership with the Royal Pharmaceutical Society, will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing. Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing.
DETAILS AND BOOKING
Continuous manufacturing
Royal Society of Chemistry, London
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of pharmaceutical products. However, despite strong regulatory support aimed at encouraging the early adoption of new technologies, which in turn would facilitate the application of modern quality management techniques to all aspects of pharmaceutical production and quality assurance; uptake by Industry has been very slow.
This symposium, held in partnership with the Royal Pharmaceutical Society, will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing. Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing.
DETAILS AND BOOKING
LAST EVENT:
Thursday 12th October 2017
Stability Challenges III: Assuring the stability of medicines from manufacture to use
Royal Society of Chemistry, London
Continuing our successful Stability Challenges series, this meeting is the third in the series and is aimed at providing the latest information and best practice on many aspects of stability testing. In this particular meeting the focus will be on data evaluation, discussing the estimation and prediction of shelf lives, including physical stability, and the effects of temperature and humidity excursions. Also the efficient application of stability testing according to lean laboratory principles will be explored along with MHRA views on stability requirements and GMDP expectations.
The focus of this meeting is to examine best practice during the distribution and storage of medicines, to ensure correct storage conditions are maintained and to ensure the quality of the medicine is maintained during use in the clinic or by the patient. The generation of data to support temperature excursions and to demonstrate in-use stability will be explored.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance, pharmaceutical development, regulatory affairs, storage and distribution in the Pharmaceutical Industry, NHS manufacturing units, Contract Research Organisations, consulting, academia, and anyone else concerned with the management and assessment of drug stability.
DETAILS
Stability Challenges III: Assuring the stability of medicines from manufacture to use
Royal Society of Chemistry, London
Continuing our successful Stability Challenges series, this meeting is the third in the series and is aimed at providing the latest information and best practice on many aspects of stability testing. In this particular meeting the focus will be on data evaluation, discussing the estimation and prediction of shelf lives, including physical stability, and the effects of temperature and humidity excursions. Also the efficient application of stability testing according to lean laboratory principles will be explored along with MHRA views on stability requirements and GMDP expectations.The focus of this meeting is to examine best practice during the distribution and storage of medicines, to ensure correct storage conditions are maintained and to ensure the quality of the medicine is maintained during use in the clinic or by the patient. The generation of data to support temperature excursions and to demonstrate in-use stability will be explored.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance, pharmaceutical development, regulatory affairs, storage and distribution in the Pharmaceutical Industry, NHS manufacturing units, Contract Research Organisations, consulting, academia, and anyone else concerned with the management and assessment of drug stability.
DETAILS
Our only sponsors are our parent professional bodies:
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical Review
JPAG members can receive a free hard copy subscription to EPR
click here
JPAG members can receive a free hard copy subscription to EPR
click here
TESTIMONIALS:
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
LATEST NEWS:
Mutagenic impurities
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Mutagenic impurities", co-written by Dr Dave Elder, Past-Chairman of the JPAG Committee. More...
Tuesday 19th September 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Mutagenic impurities", co-written by Dr Dave Elder, Past-Chairman of the JPAG Committee. More...
Tuesday 19th September 2017
Extractables and leachables
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Extractables and leachables", written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Tuesday 19th September 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Extractables and leachables", written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Tuesday 19th September 2017
Continuous manufacturing: regulatory and quality assurance challenges
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Continuous manufacturing: regulatory and quality assurance challenges ", co-written by Dr Dave Elder, Past-Chairman of the JP...
More...
Monday 11th September 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Continuous manufacturing: regulatory and quality assurance challenges ", co-written by Dr Dave Elder, Past-Chairman of the JP...
More...
Monday 11th September 2017
COOKIES AND PERSONAL DATA:
This site does not use cookies.
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).
Follow us:
| Call us: | CONTACT US | Follow us: | | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2017 Website by Delta Consultancy Services |
|